Ramasastry Saira reported option exercise involving 2,000 derivative units of Mirum Pharmaceuticals, Inc. at $0.00 for $0 on Nov 16, 2026

Option exercise
Form 4 code M. Exercise or conversion of a derivative security exempt under Rule 16b-3.
Director
DIR
Filed Nov 17, 2026

Facts from the filing

Form 4 · Derivative, table II
Disclosed value
$0Shares × reported price
Shares traded
2,000Stock Option (right to buy)
Price per share
$0.00Reported price. Read footnotes for ranges.
% of reported position traded
UnavailableThis security and ownership context
Holdings after
15,000Direct
Trade date
Nov 16, 2026Option exercise
Filed
Nov 17, 2026, 5:00 PM ET1-day reporting delay
Accession
0001547959-26-000019Code M · Transaction 404033
How reported position traded is calculated

Not calculated for derivative securities.

Row-level estimate for this security and ownership context, not the insider’s complete portfolio. Joint ownership, other transactions in the filing, amendments and footnotes can affect interpretation.

Other trades in this filing

Trade dateActivitySharesPriceValueDetails
Nov 16, 2026Sell2,000$92.28−$184,560Trade 404032
Nov 16, 2026Option exercise2,000$28.97$57,940Trade 404031
3 transaction rows in this filing. Joint filers share the same rows.

MIRM price since this filing

Daily closing prices, with the filing date and available return windows. Return methodology
MIRM · Daily closing priceDaily price data is pending. The chart appears when valid daily closes are available.
Filing dateReturn windows appear as prices become available.

Return windows are pending. The first 7-day window is eligible on Nov 24, 2026. Values appear when the daily price refresh supplies a valid close for that window. Weekends, market holidays and missing prices can delay updates.

Pre-filing1mo ago −13%1w ago +1.3%1d ago +2.2%
Returns since7d30d90d180d1y

Footnotes in full

F1: Reported transaction occurred pursuant to a Rule 10b5-1 Plan adopted by the reporting person on August 10, 2026. F2: The stock option is fully vested.